Christopher Ogden insider trades

Open-market stock purchases and sales by Christopher Ogden, Chief Financial Officer at CytomX Therapeutics, Inc, from SEC Form 4 filings since Aug 10, 2022.

Recent trades

DateStockTradeValue
Jun 15, 2026CTMX CytomX Therapeutics, IncSold$5K
Mar 17, 2026CTMX CytomX Therapeutics, IncSold$124K
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—

Companies traded

  • CTMX CytomX Therapeutics, Inc: 9 sales, last Jun 15, 2026

Get free alerts when Christopher Ogden files a new trade →